Search Results - "Bertoldero, G."

P49 A REAL‐WORLD RETROSPECTIVE‐PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE by Furlan, A., Cea, M., Zambello, R., Pavan, L., Galli, M, Clissa, C., Mangiacavalli, S., Cafro, A., Girlanda, S., Patriarca, F., Minotto, C., Bertoldero, G., Barilà, G., Pascarella, A., Lico, A., Paolini, R., Rabassi, N., Pescosta, N., Porrazzo, M., De Sabbata, G., Pompa, A., Bega, G., Cavallin, S., Guidotti, F., Semenzato, G., Zaina, C., Gherlinzoni, F.

Get full text

LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT) by Ferreri, A.J., Sassone, M.C., Angelillo, P., Zaja, F., Re, A., Spina, M., Di Rocco, A., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Arcari, A., Bertoldero, G., De Lorenzo, D., Volpetti, S., Calimeri, T., Perrone, S., Cecchetti, C., Ciceri, F., Ponzoni, M.

Get full text

POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL by Luminari, S., Marcheselli, L., Manni, M., Anastasia, A., Vitolo, U., Chiarenza, A., Rigacci, L., Angelucci, E., Fama, A., Pulsoni, A., Rattotti, S., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F., Ferreri, A.J., Tarantino, V., Bellei, M., Federico, M.

Get full text

LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R‐CVP WITH R‐CHOP AND R‐FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY by Luminari, S., Tarantino, V., Anastasia, A., Boccomini, C., Chiarenza, A., Rigacci, L., Angelucci, E., Ferrari, A., Pulsoni, A., Rattotti, S., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F., Ferreri, A.J., Vallisa, D., Balzarotti, M., Cox, M.C., Freilone, R., Marcheselli, L., Dondi, A., Manni, M., Federico, M.

Get full text

Occurrence of second neoplasms in chronic lymphocytic leukemia. Experience at Padua Hospital between 1979 and 1991 by Bertoldero, G, Scribano, G, Podda, L, Berti, R, Amadori, G

“…We report a retrospective study about the incidence of second neoplasms (SN) in patients affected by chronic lymphocytic leukemia (CLL) admitted to Padua…”
Get full text

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study by Rossi, Davide, Bruscaggin, Alessio, La Cava, Piera, Galimberti, Sara, Ciabatti, Elena, Luminari, Stefano, Rigacci, Luigi, Tucci, Alessandra, Pulsoni, Alessandro, Bertoldero, Giovanni, Vallisa, Daniele, Rusconi, Chiara, Spina, Michele, Arcaini, Luca, Angrilli, Francesco, Stelitano, Caterina, Merli, Francesco, Gaidano, Gianluca, Federico, Massimo, Palumbo, Giuseppe A

“…Though most follicular lymphoma biomarkers rely on tumor features, the host genetic background may also be relevant for outcome. Here we aimed at verifying the…”
Get full text

Electrocardiograms in hypertensive subjects from a population random sample: basic characteristics and correlations with some biological variables by Zamboni, S, Ambrosio, G B, Bertoldero, G, Bugaro, L, Dal Palù, C

“…During the initial phase of the WHO "Community Control Programme of Hypertension" in Italy, 1,190 hypertensives (of both sexes, aged 20-64) were identified…”
Get more information

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience by Aglietta, Massimo, Barkholt, Lisbeth, Schianca, Fabrizio Carnevale, Caravelli, Daniela, Omazic, Brigitta, Minotto, Coludia, Leone, Francesco, Hentschke, Patrik, Bertoldero, Giovanni, Capaldi, Antonio, Ciccone, Giovannino, Niederwieser, Dietger, Ringdén, Olle, Demirer, Tanner

“…Abstract Reduced-intensity conditioning (RIC) regimens for allogeneic hematopoietic stem cell transplantation (HCT) allowed the existence of an allogeneic…”
Get full text